FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO), which provides problem solving with its proprietary natural language processing AI engine "KIBIT" and "Concept Encoder", is March 2020, 3. Life Science AI Seminar "" at Akasaka Midtown Conference on Sunday (Friday)Life Science AI Innovation Seminar 2020"It will be held.

In fields such as medical care and pharmaceuticals, efforts to use AI are expanding, and movements toward practical application in the medical field are becoming active.Along with the numerical analysis of images and sensors, attention is being paid to efforts to analyze natural language (text information) such as conversations, treatises, and interview records with AI.

FRONTEO has been developing AI-based natural language analysis in life science since 2014, and has achieved various results in pharmaceutical companies and medical-related businesses.In this seminar, we will introduce examples and possibilities of how AI-based natural language analysis is expected in the pharmaceutical industry and medical practice.

As a special lecture, Dr. Yashiro Kishimoto, a full-time lecturer at the Department of Psychiatry and Neuroscience, Keio University School of Medicine, will talk about "the possibility of utilizing AI diagnosis in dementia", and a core member of the FRONTEO Life Science AI Business Headquarters will give an AI engine concept. Introducing the characteristic functions of Encoder and business development centered on the engine.

"Life Science AI Innovation Seminar 2020"Overview

Organized by: FRONTEO Inc.

Date: Wednesday, March 2020, 3 4:14 – 00:15

Meeting place: Tokyo Midtown Conference (XNUMX-XNUMX-XNUMX Akasaka, Minato-ku, Tokyo)

URL:　https://www.fronteo-ls-ai.com/

■ Seminar content

* The content of the seminar is subject to change.Please note.

concept encoderabout　URL: https://www.fronteo.com/products/conceptencoder/

Concept Encoder is an artificial intelligence (AI) developed by FRONTEO specially in the life science field.It was developed in 2018 for the purpose of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence (grounds).We have introduced and realized statistical methods such as the significance test, which is indispensable for "evidence-based medicine (EBM)", which is a common understanding among healthcare professionals, in natural language analysis. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with "numerical data" such as gene expression information, vitals and various test values ​​accumulated in the life science field.Patent registration number: Patent No. XNUMX

FRONTEO Inc. about
FRONTEO Inc. has developed its own artificial intelligence engine "KIBIT".^®(Kibit) ”and“ concept encoder^®(Concept encoder) ”is a data analysis company that supports information analysis such as big data.Established in August 2003 as a company that supports e-discovery (electronic discovery), which preserves, investigates, and analyzes electronic data necessary for international litigation, and digital forensic investigations.In-house developed data analysis platform "Lit i View"^®(Lit Eye View) ”,“ Predictive Coding Predictive Coding^®(Predictive Coding) ”technology is used to provide legal proceedings support to companies.The unique artificial intelligence-related technology cultivated and developed in this legal business learns "tacit knowledge" such as expert experience and intuition, and realizes prediction of future behavior from analysis of human thoughts.We have expanded into areas such as life science and business intelligence, and have achieved results in "work style reform" in addition to FinTech and RegTech. Listed on TSE Mothers on June 2007, 6 and NASDAQ on May 26, 2013.The capital is 5 thousand yen (as of March 16, 2,559,206). As of July 2019, 3, the company name has been changed from UBIC Co., Ltd. to the current company name.For more information,https://www.fronteo.com/.